Cancer stem cells: advances in knowledge and implications for cancer therapy
X Chu, W Tian, J Ning, G ** cancer stem cells with nanomaterials
WD Wang, YY Guo, ZL Yang, GL Su, ZJ Sun - ACS nano, 2023 - ACS Publications
Cancer stem cells (CSCs) drive tumor initiation, progression, and therapeutic resistance due
to their self-renewal and differentiation capabilities. Despite encouraging progress in cancer …
to their self-renewal and differentiation capabilities. Despite encouraging progress in cancer …
Nanomedicines targeting glioma stem cells
Glioblastoma (GBM), classified as a grade IV glioma, is a rapidly growing, aggressive, and
most commonly occurring tumor of the central nervous system. Despite the therapeutic …
most commonly occurring tumor of the central nervous system. Despite the therapeutic …
Exploring the microfluidic production of biomimetic hybrid nanoparticles and their pharmaceutical applications
D Fondaj, I Arduino, AA Lopedota, N Denora… - Pharmaceutics, 2023 - mdpi.com
Nanomedicines have made remarkable advances in recent years, addressing the limitations
of traditional therapy and treatment methods. Due to their improved drug solubility, stability …
of traditional therapy and treatment methods. Due to their improved drug solubility, stability …